Literature DB >> 1794928

Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.

S Fujioka1, Y Matsuzawa, K Tokunaga, T Kawamoto, T Kobatake, Y Keno, K Kotani, S Yoshida, S Tarui.   

Abstract

Visceral fat obesity (VFO) with predominant intra-abdominal fat accumulation has been shown to be more often associated with metabolic disorders than subcutaneous fat obesity (SFO). In the present study, changes in fat distribution and their effects on metabolic complications were investigated in forty premenopausal female obese patients in whom substantial weight reduction was obtained by means of a low calorie diet. Analysis of fat distribution by CT scanning demonstrated that visceral fat decreased to a greater extent than abdominal subcutaneous fat, which was particularly evident in VFO patients. On the other hand, change of fat distribution was small in SFO patients. That is, visceral to subcutaneous abdominal fat ratio (V/S ratio) decreased from 0.62 +/- 0.36 to 0.46 +/- 0.33 in VFO, whereas from 0.23 +/- 0.07 to 0.20 +/- 0.09 in SFO after weight reduction. Although obese patients, especially those with VFO, were frequently associated with glucose intolerance and hyperlipidemia, marked diminution was observed in the elevated levels of plasma glucose area on 75g OGTT, serum total cholesterol and triglyceride after weight reduction. By the examination of interrelationship between the changes in body weight, BMI, total and regional fat volume and changes in glucose and lipid metabolism, we found that the decrease in the V/S ratio and visceral fat volume were more strongly correlated with the improvement in plasma glucose and lipid metabolism compared to the decrease in body weight, BMI, total fat volume and abdominal subcutaneous fat volume. Furthermore, partial correlation analyses demonstrated that the metabolic improvements were associated with changes in visceral abdominal fat after control for changes in total adipose tissue volume.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794928

Source DB:  PubMed          Journal:  Int J Obes


  26 in total

Review 1.  Effects of diet- and exercise-induced weight loss on visceral adipose tissue in men and women.

Authors:  R Ross
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

2.  Effects of visceral adipose tissue reduction on CVD risk factors independent of weight loss: The Look AHEAD study.

Authors:  Anawin Sanguankeo; Mariana Lazo; Sikarin Upala; Frederick L Brancati; Susanne Bonekamp; Henry J Pownall; Ashok Balasubramanyam; Jeanne M Clark
Journal:  Endocr Res       Date:  2016-06-28       Impact factor: 1.720

3.  Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.

Authors:  Amaia Rodríguez; Victoria Catalán; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

Review 4.  Effects of exercise training on abdominal obesity and related metabolic complications.

Authors:  B Buemann; A Tremblay
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

5.  Effects of Weight Loss with and without Exercise on Regional Body Fat Distribution in Postmenopausal Women.

Authors:  Monica C Serra; Jacob B Blumenthal; Odessa R Addison; Ann J Miller; Andrew P Goldberg; Alice S Ryan
Journal:  Ann Nutr Metab       Date:  2017-06-09       Impact factor: 3.374

6.  Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications.

Authors:  Sotirios Tsiodras; Christos Mantzoros
Journal:  Am J Infect Dis       Date:  2006

7.  LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in ob/ob female mice.

Authors:  Amena Archer; Emilie Stolarczyk; Maria Luisa Doria; Luisa Helguero; Rosário Domingues; Jane K Howard; Agneta Mode; Marion Korach-André; Jan-Åke Gustafsson
Journal:  J Lipid Res       Date:  2013-02-27       Impact factor: 5.922

Review 8.  Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction?

Authors:  Robert Ross; Peter M Janiszewski
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

9.  Is the reduction of lower-body subcutaneous adipose tissue associated with elevations in risk factors for diabetes and cardiovascular disease?

Authors:  P M Janiszewski; J L Kuk; R Ross
Journal:  Diabetologia       Date:  2008-06-06       Impact factor: 10.122

10.  Effect of weight reduction on metabolic syndrome in Korean obese patients.

Authors:  Hye Soon Park; Su Jung Sim; Jung Yul Park
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.